A recent study showed that O-GlcNAc glycosylation increased the stability of ChREBP, promoted the expression of regulated lipogenic target genes, and aggravated hepatic steatosis in a MASLD mouse model (82). This evidence concerns the gene MLXIPL and metabolic dysfunction-associated steatotic liver disease.